BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Edinoff AN, Akuly HA, Hanna TA, Ochoa CO, Patti SJ, Ghaffar YA, Kaye AD, Viswanath O, Urits I, Boyer AG, Cornett EM, Kaye AM. Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review. Neurol Int 2021;13:387-401. [PMID: 34449705 DOI: 10.3390/neurolint13030038] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Vieira-Coelho MA, Martel F. Inhibition of kidney potassium channels by fluoxetine: In vivo and in vitro studies. Fundam Clin Pharmacol 2023;37:226-34. [PMID: 36103995 DOI: 10.1111/fcp.12833] [Reference Citation Analysis]
2 Adjei K, Adunlin G, Ali AA. Impact of Sertraline, Fluoxetine, and Escitalopram on Psychological Distress among United States Adult Outpatients with a Major Depressive Disorder. Healthcare (Basel) 2023;11. [PMID: 36900745 DOI: 10.3390/healthcare11050740] [Reference Citation Analysis]
3 Dobrek L, Głowacka K. Depression and Its Phytopharmacotherapy-A Narrative Review. Int J Mol Sci 2023;24. [PMID: 36902200 DOI: 10.3390/ijms24054772] [Reference Citation Analysis]
4 Faisal MR, Algristian H, Azizah As N. Sertraline on Obsessive Compulsive Disorders in Indonesia (A Case Study). IIMJ 2023;4:5-11. [DOI: 10.33086/iimj.v4i1.3602] [Reference Citation Analysis]
5 Elahi N, Ellahi A. Duloxetine: an effective treatment for fibromyalgia syndrome? International Journal of Surgery: Global Health 2023;6:e93-e93. [DOI: 10.1097/gh9.0000000000000093] [Reference Citation Analysis]
6 Mundula T, Baldi S, Gerace E, Amedei A. Role of the Intestinal Microbiota in the Genesis of Major Depression and the Response to Antidepressant Drug Therapy: A Narrative Review. Biomedicines 2023;11. [PMID: 36831086 DOI: 10.3390/biomedicines11020550] [Reference Citation Analysis]
7 Frank D, Gruenbaum BF, Shelef I, Zvenigorodsky V, Severynovska O, Fleidervish I, Knyazer B, Frenkel A, Zlotnik A, Kofman O, Boyko M. Blood glutamate scavenging as a novel glutamate-based therapeutic approach for post-traumatic brain injury anxiety and social impairment. Transl Psychiatry 2023;13:41. [PMID: 36739271 DOI: 10.1038/s41398-023-02329-1] [Reference Citation Analysis]
8 Hasoon J, Robinson C, Urits I, Viswanath O, Kaye AD. Burning Mouth Syndrome Treated with Mandibular and Maxillary Nerve Blocks. Health Psychol Res 2023;11:71456. [PMID: 36937081 DOI: 10.52965/001c.71456] [Reference Citation Analysis]
9 Orozco-Solano S, Silva-Castro MM, Machuca M. Case report: Serotoninergic and cholinergic syndromes induced by self-medication. Front Pharmacol 2023;14:1080249. [PMID: 36874029 DOI: 10.3389/fphar.2023.1080249] [Reference Citation Analysis]
10 González Delgado S, Garza-Veloz I, Trejo-Vazquez F, Martinez-Fierro ML. Interplay between Serotonin, Immune Response, and Intestinal Dysbiosis in Inflammatory Bowel Disease. Int J Mol Sci 2022;23. [PMID: 36555276 DOI: 10.3390/ijms232415632] [Reference Citation Analysis]
11 Gutlapalli SD, Chaudhuri D, Khan KI, Al Shouli R, Allakky A, Ferguson AA, Khan AI, Abuzainah B, Mohammed L. Statins and Antidepressants: A Comprehensive Review and Clinical Outlook of the Risks and Benefits of Co-prescription (2022). Cureus 2022;14:e32331. [PMID: 36632257 DOI: 10.7759/cureus.32331] [Reference Citation Analysis]
12 Musabirova G, Engberg O, Gupta A, Roy DS, Maiti S, Huster D. Serotonergic drugs modulate the phase behavior of complex lipid bilayers. Biochimie 2022;203:40-50. [PMID: 35447219 DOI: 10.1016/j.biochi.2022.04.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Krylatykh VY, Aleshkina GA. Comparative study of the effect of vortioxetine on sexual function in outpatient patients with non-psychotic depression. Medical Journal of the Russian Federation 2022;28:333-343. [DOI: 10.17816/medjrf111063] [Reference Citation Analysis]
14 Kabra A, Garg R, Brimson J, Živković J, Almawash S, Ayaz M, Nawaz A, Hassan SSU, Bungau S. Mechanistic insights into the role of plant polyphenols and their nano-formulations in the management of depression. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1046599] [Reference Citation Analysis]
15 Singh A, Saidulu D, Gupta AK, Kubsad V. Occurrence and fate of antidepressants in the aquatic environment: Insights into toxicological effects on the aquatic life, analytical methods, and removal techniques. Journal of Environmental Chemical Engineering 2022. [DOI: 10.1016/j.jece.2022.109012] [Reference Citation Analysis]
16 Lee J, Chang SM. Confounding by Indication in Studies of Selective Serotonin Reuptake Inhibitors. Psychiatry Investig 2022;19:873-83. [PMID: 36444151 DOI: 10.30773/pi.2022.0209] [Reference Citation Analysis]
17 Md. Shahazul Islam, Rajib Hossain, Taukir Ahmed, Md. Mizanur Rahaman, Khattab Al-Khafaji, Rasel Ahmed Khan, Chandan Sarkar, Mehedi Hasan Bappi, Edlane Martins de Andrade, Isaac Moura Araújo, Henrique Douglas Melo Coutinho, Grażyna Kowalska, Radosław Kowalski, Muhammad Asif Hanif, Muhammad Torequl Islam. Anxiolytic-like Effect of Quercetin Possibly through GABA Receptor Interaction Pathway: In Vivo and In Silico Studies. Molecules 2022;27:7149. [PMID: 36363979 DOI: 10.3390/molecules27217149] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Kotajima-Murakami H, Ide S, Ikeda K. GIRK Channels as Candidate Targets for the Treatment of Substance Use Disorders. Biomedicines 2022;10:2552. [PMID: 36289814 DOI: 10.3390/biomedicines10102552] [Reference Citation Analysis]
19 Zastrozhin M, Skryabin V, Petukhov A, Pankratenko E, Pozdniakov S, Ivanchenko V, Horyaev D, Vlasovskih R, Bryun E, Sychev D. Effects of CYP2D6*4 polymorphism on the steady-state concentration of paroxetine in patients diagnosed with depressive episode and comorbid alcohol use disorder. J Psychopharmacol 2022;36:1146-50. [PMID: 35861192 DOI: 10.1177/02698811221112939] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Otsuka A, Tamaya M, Toda A. Effect of the dietary intake of fish oil on psycho-social behavioral disorder caused by social-defeat stress. Physiol Behav 2022;254:113913. [PMID: 35835180 DOI: 10.1016/j.physbeh.2022.113913] [Reference Citation Analysis]
21 Huang A, Huang S. Increased Vigorous Exercise and Decreased Sedentary Activities are associated with Decreased Depressive Symptoms in United States Adults: Analysis of the National Health and Nutrition Examination Survey (NHANES) 2017-2020. (Preprint).. [DOI: 10.2196/preprints.42925] [Reference Citation Analysis]
22 Gutlapalli SD, Prakash K, Swarnakari KM, Bai M, Manoharan MP, Raja R, Jamil A, Csendes D, Desai A, Desai DM, Alfonso M. The Risk of Fatal Arrhythmias Associated With Sertraline in Patients With Post-myocardial Infarction Depression. Cureus 2022. [DOI: 10.7759/cureus.28946] [Reference Citation Analysis]
23 Wu J, Peng Z, Wu Q, Tang RWL, Dong T, Wang H, Tsim KWK. The water extract of Aloe vera prevents fluoxetine-induced multiple-drug resistance of E. coli by inhibiting reactive oxygen species formation and membrane permeability. Phytomedicine 2022;106:154421. [PMID: 36054995 DOI: 10.1016/j.phymed.2022.154421] [Reference Citation Analysis]
24 Lu J, Huang C, Lu Q, Lu X. Therapeutic and Prophylactic Effects of Amphotericin B Liposomes on Chronic Social Defeat Stress-Induced Behavioral Abnormalities in Mice. Front Pharmacol 2022;13:918177. [DOI: 10.3389/fphar.2022.918177] [Reference Citation Analysis]
25 Zastrozhin MS, Skryabin V, Rwere F, Petukhov AE, Pankratenko EP, Pozdniakov SA, Ivanchenko VA, Noskov VV, Zaytsev IA, Vinokurova NV, Horyaev DS, Vlasovskih RV, Bryun EA, Sychev DA. Influence of CYP2C19*17 Genetic Polymorphism on the Steady-State Concentration of Escitalopram in Patients with Recurrent Depressive Disorder. Psychopharmacol Bull 2022;52:8-19. [PMID: 35815173] [Reference Citation Analysis]
26 Artamonov NM, FSAEI HE Pirogov Russian National Research Medical University of the Ministry of Health of Russia, Moscow, SAHI Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan, Maksimov ML, Zvegintseva AA, FSAEI HE Pirogov Russian National Research Medical University of the Ministry of Health of Russia, Moscow, SAHI Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan, FSAEI HE Pirogov Russian National Research Medical University of the Ministry of Health of Russia, Moscow, SAHI Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan. Fluvoxamine and fluoxetine in the treatment of patients with the novel coronavirus infection. Chief Medical Officer 2022. [DOI: 10.33920/med-03-2206-09] [Reference Citation Analysis]
27 Rabin EE, Kim M, Mozny A, Cardoza K, Bell AC, Zhai L, Bommi P, Lauing KL, King AL, Armstrong TS, Walunas TL, Fang D, Roy I, Peipert JD, Sieg E, Mi X, Amidei C, Lukas RV, Wainwright DA. A systematic review of pharmacologic treatment efficacy for depression in older patients with cancer. Brain, Behavior, & Immunity - Health 2022;21:100449. [DOI: 10.1016/j.bbih.2022.100449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Sotille R, Singh H, Weisman A, Vida T. Unraveling the Mysteries of Mental Illness With Psilocybin. Cureus 2022;14:e25414. [PMID: 35769681 DOI: 10.7759/cureus.25414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Kotajima‐murakami H, Takano A, Hirakawa S, Ogai Y, Funada D, Tanibuchi Y, Ban E, Kikuchi M, Tachimori H, Maruo K, Kawashima T, Tomo Y, Sasaki T, Oi H, Matsumoto T, Ikeda K. Ifenprodil for the treatment of methamphetamine use disorder: An exploratory, randomized, double‐blind, placebo‐controlled trial. Neuropsychopharm Rep. [DOI: 10.1002/npr2.12232] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Duică L, Antonescu E, Totan M, Boța G, Silișteanu SC. Borderline Personality Disorder “Discouraged Type”: A Case Report. Medicina 2022;58:162. [DOI: 10.3390/medicina58020162] [Reference Citation Analysis]
31 Gao Z, Wang J, Gao M, Song T, Gao X, Qiao M, Gao J. Acupuncture combined with SSRIs in the treatment of perimenopausal depressive disorder: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2022;101:e28558. [PMID: 35060514 DOI: 10.1097/MD.0000000000028558] [Reference Citation Analysis]
32 Marineci CD. Drugs for mood disorders. Farmacist ro 2022;5:6. [DOI: 10.26416/farm.208.5.2022.7143] [Reference Citation Analysis]
33 Abdel-Hamed AR, Abo-Elmatty DM, Essawy SS, Taha MA, Huwait EA, Alghamdi L, Al-Ghamdi MA. Antisecretory and antioxidative effects of the antidepressants fluvoxamine and mirtazapine on water immersion stress and pyloric ligation-induced gastric ulcer in rats. Int J Health Sci (Qassim) 2022;16:25-34. [PMID: 35599943] [Reference Citation Analysis]
34 Clauss NJ, Daws LC. Neurotransmitter Transporters and Their Role in the Pharmacological Actions of Therapeutic and Abused Drugs. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00172-9] [Reference Citation Analysis]
35 Flores-Burgess A, Millón C, Gago B, García-Durán L, Cantero-García N, Puigcerver A, Narváez JA, Fuxe K, Santín L, Díaz-Cabiale Z. Galanin (1-15) Enhances the Behavioral Effects of Fluoxetine in the Olfactory Bulbectomy Rat, Suggesting a New Augmentation Strategy in Depression. Int J Neuropsychopharmacol 2022;25:307-18. [PMID: 34891163 DOI: 10.1093/ijnp/pyab089] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Alvarenga ME, Murphy BM, Jackson AC. Emerging approaches to the treatment of depression in patients with cardiovascular disease. British Journal of Cardiac Nursing 2021;16:1-4. [DOI: 10.12968/bjca.2021.0111] [Reference Citation Analysis]